大博医疗收盘上涨9.99%，滚动市盈率43.26倍，总市值172.27亿元

Group 1 - The core viewpoint of the news is that Dabo Medical's stock has seen a significant increase, with a closing price of 41.61 yuan, up 9.99%, and a rolling PE ratio of 43.26, marking a new low in 650 days [1] - Dabo Medical's total market capitalization is 17.227 billion yuan, and it ranks 84th in the medical device industry based on PE ratio, which has an average of 51.83 and a median of 37.23 [1] - The company experienced a net inflow of 48.9197 million yuan in main funds on July 15, with a total inflow of 73.1049 million yuan over the past five days [1] Group 2 - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with key products including intramedullary nails, hollow nails, and various orthopedic implants [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, up 67.04%, with a gross profit margin of 69.64% [1] - In comparison to other companies in the industry, Dabo Medical's PE ratio of 43.26 is higher than the industry average of 51.83 and the median of 37.23 [2]